Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

Market Cap	999.95M -19.7%
Revenue (ttm)	991.69M +4.1%
Net Income	93.50M +7.0%
EPS	0.09 +0.9%
Shares Out	n/a
PE Ratio	10.69
Forward PE	7.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	8,176
Open	1.000
Previous Close	n/a
Day's Range	1.000 - 1.000
52-Week Range	0.935 - 1.430
Beta	0.47
RSI	47.56
Earnings Date	Feb 25, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,708
• Stock Exchange: OTCMKTS
• Ticker Symbol: GNMLF

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN